pharmaphorum| News & views on pharma and biotech’s evolving future

Patients

Man lies on floor next to spilled pill bottle, reference to overdose

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

News

Acquisitive Lilly offers $2.88bn for Merida Bio

Lilly has continued its lengthy streak of acquisitions in 2026 with a $2.88 billion agreement to buy immunology and inflammation specialist Merida.

Oncology

How IRA, MFN, and HTA are rewriting oncology launch strategy...

News

ESC26: Heart attack reclassification rights gender imbalance

New definitions of myocardial infarction released at ESC 2026 recognise that there are different causes - and could lead to better treatment of women.

Market Access

Navigating Europe's AI regulatory labyrinth: A strategic gui...

For US drug developers, bringing AI tools across the Atlantic introduces steep regulatory hurdles.

Featured Content

Patients

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

Oncology

How IRA, MFN, and HTA are rewriting oncology launch strategy...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Sponsored

From Alzheimer’s disease research to the real-world setting:...

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.

Newsletters and Deep Dive
digital magazine

Latest News

News

Acquisitive Lilly offers $2.88bn for Merida Bio

Lilly has continued its lengthy streak of acquisitions in 2026 with a $2.88 billion agreement to buy immunology and inflammation specialist Merida.

News

ESC26: Heart attack reclassification rights gender imbalance

New definitions of myocardial infarction released at ESC 2026 recognise that there are different causes - and could lead to better treatment of women.

News

ESC26: Isomab safety evidence on blood vessel growth for CAD

Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.

News

Roivant wins FDA approval for first targeted dermatomyositis...

Roviant & Priovant Therapeutics finally secure US approval for once-daily oral TYK2/JAK1 inhibitor, Lisraya (brepocitinib), for dermatomyositis.

Views & Analysis

Patients

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

Market Access

Navigating Europe's AI regulatory labyrinth: A strategic gui...

For US drug developers, bringing AI tools across the Atlantic introduces steep regulatory hurdles.

R&D

Why the future of eSource starts with the research site

Capturing data digitally at source can significantly reduce the workflow for sites, yet, implementing it across studies has been rather unattainable.

Market Access

Biotech funding has returned. The bar has moved with it.

For biotech sponsors, the question worth asking is not whether the rebound is real, but what it is actually rewarding.

Deep Dive

Oncology

How IRA, MFN, and HTA are rewriting oncology launch strategy...

R&D

Cancer misinformation is a trust problem, not just an inform...

Oncology

Solving the ovarian cancer diagnostic and treatment pathway ...

Oncology

Early onset cancer new approach treatment

White Papers & Webinar

R&D

Sponsored

From Alzheimer’s disease research to the real-world setting:...

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.

Digital

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

R&D

From obesity to outcomes abstract visual

Sponsored

The future of cardiometabolic trials: From obesity to outcom...

Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO

R&D

Sponsored

A data-driven guide to small molecule drug discovery and dev...

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

Podcasts & Video

Patients

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

pharmaphorum podcast Episode 272, Dr Harpreet Singh, Precision for Medicine

Understanding Operation Trialblazer, with Dr Harpreet Singh

Dr Harpreet Singh, CMO at Precision for Medicine, brings both an insider and outsider perspective to discussing Operation TRIALBLAZER.

R&D

Prevent-Stop-Cure: Diagnostics & chronic liver disease, with...

Partner Content

Event

Media Partner

AI, Forecasting, Insights and Analytics for Smarter Decision...

Learn from case studies, expert-led panels, roundtable discussions, and interactive workshops on Gen AI-powered forecasting

Event

Media Partner

30th Portfolio Decision-Making & Prioritisation for Pharma

Pharmaceutical portfolio decision-making is facing structural pressure.

Event

Media Partner

R&D Governance, Controlling and Innovation for Pharma

The Marcus Evans R&D Governance, Controlling, and Innovation for Pharma conference will take place at the Crowne Plaza - Frankfurt Congress Hotel

Event

Partner Content

The MFN effect: what payers expect and how Pharma should res...

A live webinar and audience Q&A with practical insights from global payer research and leading payer experts

Event

Partner Content

The Pharmaceutical Launch Excellence Summit

Where pharma leaders share strategies for successful drug launches.

Featured Content

Editor's Picks

Latest News

Views & Analysis

Deep Dive

White Papers & Webinar

Podcasts & Video

Partner Content